Delayed bio-stimulant approvals
Approvals for three bio-stimulant products are expected by end of Q4 FY26; any delay could impact Q1 FY27 sales, as peak season starts in July.
DHANUKA / Q3-FY26 / risks
Keep the risk register visible.
Dhanuka Agritech · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
El Niño impact on kharif season
Early El Niño predictions could affect monsoon rains and farmer incomes, potentially reducing demand for agrochemicals in the kharif season.
Supply chain risks in Bayer product transition
Transition of Bayer products to Dhanuka's control involves regulatory and supply chain dependencies; any disruption could affect sales.
Inventory buildup from misfired sales plan
Inventory of imported molecules increased due to lower-than-expected sales, potentially leading to higher carrying costs or write-downs.